Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty (EPCAT II)

全髋关节和膝关节置换术后延长静脉血栓栓塞预防比较利伐沙班与阿司匹林 (EPCAT II)

• 批准号: 254987
• 负责人: Anderson David R
• 金额: $ 221.82万
• 依托单位: Nova Scotia Health Authority (Halifax)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2012
• 资助国家: 加拿大
• 起止时间: 2012-03-01 至 2016-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=254987&lang=en
• 关键词: Double-Dummy; Extended Venous Thromboembolism Prophylaxis; Out Of Hospital; Randomized; Total Hip Arthroplasty; Total Knee Arthroplasty

Blood clots in the legs and lungs are common complications following hip and knee replacement surgery. Guidelines state to give anticoagulants (blood thinners) for up to 14 days after knee replacement and 35 days after hip replacement. In this study we in

腿部和肺部的血块是髋关节和膝关节置换手术后常见的并发症。指导方针规定 在膝关节置换后14天和髋关节置换后35天内服用抗凝剂(血液稀释剂)。在这 研究我们在